Fortis Healthcare Limited reported strong financial growth for the quarter and year ended March 31, 2026. The company achieved an annual revenue of ₹912,784 lacs, representing a significant increase over the previous year. Driven by strong operational performance, the Board of Directors has recommended a final dividend of ₹1 per equity share, subject to shareholder approval. The company also confirmed its strategic focus through continued business expansions and effective cost management strategies.
Fiscal Performance Highlights
For the financial year ended March 31, 2026, Fortis Healthcare demonstrated resilient growth, with annual revenue from operations reaching ₹912,784 lacs, compared to ₹778,275 lacs in the previous year. The net profit for the year rose to ₹106,419 lacs, up from ₹80,938 lacs in the prior period. EBITDA also saw a substantial increase, reaching ₹213,564 lacs for the fiscal year, underscoring strong operational efficiency across all business units.
Segment Breakdown
The company maintains two primary reportable segments: Healthcare and Diagnostics. The Healthcare segment delivered strong results, contributing ₹777,269 lacs to total revenue, while the Diagnostics segment generated ₹152,656 lacs. Both segments reported positive growth in segment results, reflecting the group’s integrated approach to delivering medical services.
Shareholder Returns and Strategic Appointments
In addition to strong financial results, the Board of Directors has recommended a final dividend of ₹1 per equity share (10% of the face value of ₹10 each) for the 2025-26 financial year. This payment will be disbursed within 30 days of approval at the upcoming Annual General Meeting. Furthermore, the company has appointed M/s Jitender, Navneet & Co. as the Cost Auditor for the 2026-27 financial year, ensuring continued diligence in cost management.
Strategic Outlook and Expansion
Fortis Healthcare continues to strengthen its network. Notable developments include the acquisition of TMI Healthcare Private Limited, which operates a 125-bed hospital in Bengaluru, for a cumulative value of ₹43,386 lacs. Additionally, the company has implemented an operation and maintenance service agreement to manage five hospitals and one clinic, further expanding its healthcare footprint. Management remains focused on leveraging core competencies in healthcare delivery to sustain long-term value creation.
Source: BSE
